Abstract:Until now, observational studies have explored the impact of vitamin C intake on Alzheimer’s disease (AD) risk, however, reported ambiguous findings. To develop effective therapies or prevention, the causal link between vitamin C levels and AD should be established. Here, we selected 11 plasma vitamin C genetic variants from a large-scale plasma vitamin C GWAS dataset (N = 52,018) as the potential instrumental variables. We extracted their corresponding summary statistics from large-scale IGAP clinically diagnosed AD GWAS dataset (N = 63,926) and UK Biobank AD proxy phenotype GWAS dataset (N = 314,278), as well as two UK Biobank subgroups including the maternal AD group (27,696 cases of maternal AD and 260,980 controls) and paternal AD group (14,338 cases of paternal AD and 245,941 controls). We then performed a Mendelian randomization (MR) study to evaluate the causal association between plasma vitamin C levels and the risk of AD and AD proxy phenotype. Meanwhile, we further verified these findings using a large-scale cognitive performance GWAS dataset (N = 257,841). In IGAP, we found no significant causal association between plasma vitamin C levels and the risk of AD. In UK Biobank, we found that per 1 SD increase in plasma vitamin C levels (about 20.2 μmol/l) was significantly associated with the reduced risk of AD proxy phenotype (OR = 0.93, 95% CI 0.88–0.98, P = 7.00E−03). A subgroup MR analysis in UK Biobank indicated that per 1 SD increase in plasma vitamin C levels could significantly reduce the risk of AD proxy phenotype in the maternal AD group (OR = 0.89, 95% CI 0.84–0.94, P = 7.29E−05), but not in the paternal AD group (OR = 1.02, 95% CI 0.92–1.12, P = 7.59E−01). The leave-one-out permutation further showed that the SLC23A1 rs33972313 variant largely changed the precision of the overall MR estimates in all these four GWAS datasets. Meanwhile, we did not observe any significant causal effect of plasma vitamin C levels on the cognitive performance. We demonstrated that there may be no causal association between plasma vitamin C levels and the risk of AD in people of European descent. The insistent findings in clinically diagnosed AD and AD proxy phenotype may be caused by the phenotypic heterogeneity.

Vitamin D, Cognition, and Alzheimer's Disease: Observational and Two-Sample Mendelian Randomization Studies

Impact of Vitamin D Binding Protein Levels on Alzheimer's Disease: A Mendelian Randomization Study.

The Impact of Plasma Vitamin C Levels on the Risk of Cardiovascular Diseases and Alzheimer's Disease: A Mendelian Randomization Study.

Vitamin D and Cognitive Performance in Older Adults: A Cross-Sectional and Mendelian Randomization Study

Vitamin D status and cognitive performance in community-dwelling adults: A dose-response meta-analysis of observational studies

Vitamin D Levels and Cognition in Elderly Adults in China.

Analyzing the Correlation of Vitamin D and Cognitive Function in Community Elders over 60 Years Old

Effects of vitamin D 3 supplementation on cognition and blood lipids: a 12-month randomised, double-blind, placebo-controlled trial.

A Putative Causality of Vitamin D in Common Diseases: A Mendelian Randomization Study.

Vitamin D Concentration and Risk of Alzheimer Disease: A Meta-Analysis of Prospective Cohort Studies.

Causal association of genetically determined circulating vitamin D metabolites and calcium with multiple sclerosis in participants of European descent

Effects of vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer’s disease: a randomised, double-blind, placebo-controlled trial

The Role of Vitamin D as a Biomarker in Alzheimer's Disease

Prevalence and patterns of vitamin D deficiency and its role in cognitive functioning in a cohort from South India

The Impact of Vitamin D and Cognitive Function on All-Cause Mortality Among Older Chinese Adults: A Population-based Longitudinal Study

Vitamin D Levels and the Risk of Cognitive Decline in Chinese Elderly People: the Chinese Longitudinal Healthy Longevity Survey

Mendelian Randomization to Evaluate the Effect of Plasma Vitamin C Levels on the Risk of Alzheimer’s Disease

Vitamin D Supplementation Improves Cognitive Function Through Reducing Oxidative Stress Regulated by Telomere Length in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized Controlled Trial.

Association of Vitamin D Levels with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Studies

Combined Associations of Vitamin D and Cognitive Function with All-Cause Mortality among Older Adults in Chinese Longevity Areas: A Prospective Cohort Study.

Circulating vitamin E levels and Alzheimer's disease: a Mendelian randomization study.